Axogen (AXGN) Interest & Investment Income (2010 - 2026)
Axogen's quarterly Interest & Investment Income came in at $768000.0 in Q1 2026, up 182.35% year-on-year from $272000.0 in Q1 2025, and up 118.18% quarter-over-quarter from $352000.0 in Q4 2025.
Axogen has reported Interest & Investment Income for 11 years, with the latest figure at $768000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 182.35% year-over-year to $768000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 48.57% YoY), and the FY2025 full-year result was $1.2 million, up 2.37% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $768000.0, up from $352000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $768000.0 in Q1 2026, with the low at -$46000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $301941.2, with a median of $296000.0 recorded in 2024.
- Peak annual rise in Interest & Investment Income reached 2953.85% in 2022, while the deepest fall reached 235.29% in 2022.
- Tracing AXGN's Interest & Investment Income over 5 years: stood at $397000.0 in 2022, then fell by 15.37% to $336000.0 in 2023, then decreased by 3.27% to $325000.0 in 2024, then advanced by 8.31% to $352000.0 in 2025, then jumped by 118.18% to $768000.0 in 2026.
- The last three Interest & Investment Income figures came in at $768000.0 (Q1 2026), $352000.0 (Q4 2025), and $319000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | 768,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 768,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 272,000.00 |
| Dec 31, 2024 | 325,000.00 |
| Sep 30, 2024 | 296,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 293,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 235,000.00 |
| Mar 31, 2023 | 549,000.00 |
| Dec 31, 2022 | 397,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 34,000.00 |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Jun 30, 2020 | 237,000.00 |
| Mar 31, 2020 | 311,000.00 |
| Dec 31, 2019 | 439,000.00 |
| Sep 30, 2019 | 555,000.00 |
| Jun 30, 2019 | 654,000.00 |
| Mar 31, 2019 | 716,000.00 |
| Dec 31, 2018 | 641,000.00 |
| Sep 30, 2018 | 727,000.00 |
| Jun 30, 2018 | 156,000.00 |
| Jun 30, 2011 | 23,749.00 |
| Jun 30, 2010 | 4,235.00 |